No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | general cells |
IFO50070 |
Balb/3T3-A31-1-1 |
mouse |
embryo, whole |
fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) |
|
2 | general cells |
IFO50110 |
C6 |
rat |
brain |
glial tumor, GFAP-positive |
|
3 | general cells |
IFO50268 |
EHS |
mouse |
spontaneous tumor |
This cell line secretes basement membrane matrix including laminin and type IV collagen. |
|
4 | general cells |
IFO50286 |
SF126 |
human |
brain |
glioblastoma multiforme, GFAP-negative |
|
5 | general cells |
IFO50313 |
SNG-M |
human |
metastatic lymph node |
endometrial adenocarcinoma |
|
6 | general cells |
JCRB0117 |
B104 |
human |
blood |
Human B cell lymphoma cell line with EBNA(-). IgD and IgM were expressed on the surface of cells. |
|
7 | general cells |
JCRB0133 |
KHM-1B |
human |
pleural effusion |
myeloma, multiple, with hyperamylasemia. |
|
8 | general cells |
JCRB0144.2D |
LYM-1.P3D |
rat |
lymph node near colon cancer |
Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer. |
|
9 | general cells |
JCRB0149 |
Bhas 42 |
mouse |
whole body of embryo |
BALB 3T3 A31-1-1 cell line transfected with H-ras gene. The cell line keeps characteristics of the contact inhibition and the transfomation is induced by phorbol ester alone. No initialization required. (Strain problem was found. Refer Important Notice at cell detail page.) |
|
10 | general cells |
JCRB0169 |
Lu-134-B |
human |
lung |
Small cell lung carcinoma cell line established through heterotransplanted tumor. |
|
11 | general cells |
JCRB0198 |
OSC-19 |
human |
tongue |
Human squamous cell carcinoma cell line from tongue tumor with serum free cell culture. |
|
12 | general cells |
JCRB0246 |
RC-1 |
rabbit |
cornea |
cornea, (white rabbit) |
|
13 | general cells |
JCRB0250 |
NEC8 |
human |
testis |
testicular germ cell tumor |
|
14 | general cells |
JCRB0267 |
PC12MS |
rat |
chromaffin cell |
Moderately NGF sensitive clone of rat PC12 cell line. |
|
15 | general cells |
JCRB0416 |
Ac2F(DT) |
rat |
liver transformed |
Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat) |
|
16 | general cells |
JCRB0426 |
HuH28 |
human |
liver bile duct |
Human liver, bile duct carcinoma cell line. |
|
17 | general cells |
JCRB0427 |
HuO9 |
human |
bone (right femur) |
A cell line established from a human osteosarcoma transplanted into athymic nude mice after fifth passages. The cell line expressed 1,25(OH)2D3-responsive alikaline phosphatase and produced tumors in the dorsum of nude mice. |
|
18 | general cells |
JCRB0536 |
TIG-121 |
human |
|
skin, normal diploid fibroblast |
|
19 | general cells |
JCRB0710 |
EJ-1 |
human |
|
The cell line EJ-1 was identified to be the same cell line as the T24. |
|
20 | general cells |
JCRB0718.1 |
RLC-10.P3 |
rat |
liver |
Rat normal cell line cultured with serum free medium for long passages. |
|
21 | general cells |
JCRB0814 |
VMRC-LCD |
human |
lung |
adenocarcinoma |
|
22 | general cells |
JCRB1001.1 |
MS-653-A |
rat |
tumor tissue |
Highly metastatic rat fibrosarcoma cell line induced by methylcholanthrene. |
|
23 | general cells |
JCRB1006.3 |
OUMS-36T-3 |
human |
embryo |
hTRT gene transfected normal human embryo fibroblast cell line. |
|
24 | general cells |
JCRB1006.4 |
OUMS-36T-4 |
human |
embryo |
hTRT gene transfected normal human embryo fibroblast cell line. |
|
25 | general cells |
JCRB1011 |
KMRC-2 |
human |
kidney |
Human tumor cell line from kidney. Clear cell renal carcinoma cell line. |
|
26 | general cells |
JCRB1052 |
PA-1/6TG-r |
human |
ascites fluid |
Human teratocarcinoma cell line PA-1 with 6TG resistance. |
|
27 | general cells |
JCRB1075.0 |
IM95 |
human |
stomach |
Human gastric cancer cell line. |
|
28 | general cells |
JCRB1077 |
DD-762 |
mouse |
tumor tissue |
Mouse mammary tumor cell line producing MuMTV. |
|
29 | general cells |
JCRB1200 |
NCC-RbC-53 |
human |
primary retinoblastoma |
Human retinoblastoma cell line. The growth is extremely slow. |
|
30 | general cells |
JCRB1201 |
GCH-nu-YS |
human |
nude mouse-transplanted tumor |
Human gestational choriocarcinoma cell line. |
|
31 | general cells |
JCRB1204 |
KUM7 |
mouse |
Bone marrow |
Osteoblastic cell line |
|
32 | general cells |
JCRB1222.05 |
HGH2.6.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
33 | general cells |
JCRB1333 |
NCC-CoC-K115L |
human |
Lymphatic node (colon) |
Human colon cancer cell line (metastasis peripheral lymph node). |
|
34 | general cells |
JCRB1342.05 |
MOR83.3.10 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
35 | general cells |
JCRB1342.07 |
MOR124.2.2 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
36 | general cells |
JCRB1344 |
delta-47 |
human |
ascites |
Human myeloma cell line secreting IgD. |
|
37 | general cells |
JCRB1367 |
Vn1919 cl49 |
mouse |
brain |
neuroglial and neuronal character coexpressing ependymoma cell line. |
|
38 | general cells |
JCRB1368 |
Vn1919 cl59 |
mouse |
brain |
neuroglial and neuronal character coexpressing ependymoma cell line. |
|
39 | genetically-modified cells |
JCRB1371 |
GS-3A4-HepG2 |
human |
Liver |
Human glutamine synthetase gene and drug-metabolizing CYP3A4 gene introduced Hep G2 cells. |
|
40 | luciferase-expressing cancer cells |
JCRB1379 |
MKN45-Luc |
human |
stomach, metastatic tumor in liver |
Luciferase stably expressing cell line (MKN45:Human Gastric Cancer). |
|
41 | general cells |
JCRB1384 |
STR-428 |
human |
ascites |
Human HHV-8 negative malignant effusion lymphoma (DLBCL). |
|
42 | general cells |
JCRB1385 |
CAS-9 |
mouse x rat |
|
Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/Fibronectin. |
|
43 | luciferase-expressing cancer cells |
JCRB1406 |
PC-3-Luc |
human |
prostate |
Luciferase stably expressing cell line (PC-3; Human Prostate Cancer). |
|
44 | luciferase-expressing cancer cells |
JCRB1448 |
BxPC-3-Luc#2 |
human |
pancreas |
Luciferase stably expressing cell line (BxPC-3; Human pancreatic adenocarcinoma cell line). |
|
45 | luciferase-expressing cancer cells |
JCRB1474 |
B16-F0-Luc |
mouse |
skin |
Luciferase stably expressing cell line (B16-F0; Mouse melanoma cell line). |
|
46 | luciferase-expressing cancer cells |
JCRB1508 |
HCC-1937/CMV-Luc |
human |
mammary gland; breast |
Luciferase stably expressing cell line (HCC1937; Human breast cancer cell line). |
|
47 | genetically-modified cells |
JCRB1523 |
POLK CD MSH- |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH-, POLK catalytically dead, TK+/+) |
|
48 | genetically-modified cells |
JCRB1533 |
293 TRE/Cont |
human |
kidney |
Control 293 cell line for 293 TRE/FLAG-POLK. |
|
49 | genetically-modified cells |
JCRB1534 |
IKK-i-DEF |
mouse |
embryo |
Mouse embryonic fibroblasts prepared from IkB kinase (IKK-i) deficient mice. |
|
50 | genetically-modified cells |
JCRB1538 |
EMC100 |
human |
uterine endometrium |
Immortalized human uterine endometrial gland-derived mesenchymal cell line. |
|
51 | general cells |
JCRB1539 |
HAC-2 |
human |
ascites |
Human ovary cancer cell line derived from mesonephros. |
|
52 | immortalized mesenchymal stem cell |
JCRB1546 |
UCB408E7-TERT34 |
human |
umbilical cord blood |
Immortalized human umbilical cord blood-derived mesenchymal stem cells. |
|
53 | genetically-modified cells |
JCRB1554 |
MMNK-1 |
human |
|
Highly differentiated immortalized human cholangiocyte cell line. |
|
54 | genetically-modified cells |
JCRB1555 |
HAdpc-26-E6-Bmi-1-TERT |
human |
|
Immortalized human adipose tissue-derived mesenchymal stem cells. |
|
55 | genetically-modified cells |
JCRB1563 |
HAdpc-29-E7-TERT |
human |
|
Immortalized human adipose tissue-derived mesenchymal stem cells. |
|
56 | genetically-modified cells |
JCRB1564 |
TMNK-1 |
human |
liver |
Immortalized human-liver endothelial cell line with SV40T and hTERT. (Note: recommended medium is very specific.) |
|
57 | general cells |
JCRB1568 |
KKU-100 |
human |
biliary tract |
Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. |
|
58 | general cells |
JCRB1571 |
F6B3 |
mouse |
brain |
Mouse cell line derived from mouse brain tumor. |
|
59 | luciferase-expressing cancer cells |
JCRB1586 |
HSC-5-Luc |
human |
skin |
Luciferase stably expressing cell line. A cell line derived from human skin squamous cell carcinoma having anaplastic epithelioid features. |
|
60 | general cells |
JCRB1603 |
hTf18-10C |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
61 | general cells |
JCRB1616 |
hTf/CHO-S #17 |
hamster, Chinese |
ovary |
This cell line produce human transferrin. |
|
62 | general cells |
JCRB1617 |
hTf9-11E |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
63 | general cells |
JCRB1626 |
pREP4 cont/CHO-S #5 |
hamster, Chinese |
ovary |
pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS). |
|
64 | luciferase-expressing cancer cells |
JCRB1681 |
MIA PaCa-2/CMV-Luc |
human |
pancreas |
Luciferase stably expressing cell line (MIA PaCa-2; Human Pancreatic Cancer Cell Line). |
|
65 | general cells |
JCRB1771 |
KKK-D049 |
human |
intrahepatic bile duct |
Human well differentiated tubular adenocarcinoma cell line established from biliary tract. |
|
66 | general cells |
JCRB1777 |
KKK-D131 |
human |
intrahepatic bile duct |
Human well differentiated tubular adenocarcinoma cell line established from biliary tract. |
|
67 | general cells |
JCRB1823 |
NALM-20 |
human |
peripheral bood |
Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line. |
|
68 | general cells |
JCRB1855 |
Cx43KOM104-E7(+/+) |
mouse |
embryo, whole |
Connexin 43 +/+ mouse embryo-derived fibroblast cell line. (embryo from Connexin 43 +/- parents) |
|
69 | general cells |
JCRB1856 |
NALM-37 |
human |
peripheral bood |
B-cell precurrsor (BCP) acute lymphoblastic leukemia (ALL) cell line. Derived from the same patient as NALM-36 |
|
70 | general cells |
JCRB1864 |
HSC-39 |
human |
ascites |
Human signet ring cell gastric carcinoma cell line establised in vitro from ascites. |
|
71 | general cells |
JCRB1885 |
HSC-64 |
human |
ascites |
Human gastric carcinoma (poor differentiated adenocarcinoma) cell line establised in vitro from ascites. |
|
72 | general cells |
JCRB1916 |
TCC-NECT-2 |
human |
duodenum |
Duodenal neuroendocrine tumor. Derived from metastatic site: Ascites. |
|
73 | general cells |
JCRB4004 |
KE-43C4 |
human |
primary colonic carcinoma |
Well-differentiated adenocarcinoma obtained by cloning KE-43 |
|
74 | general cells |
JCRB9036 |
104C1 |
guinea pig |
fetal body |
fetal carcass, benzo(a)pyrene transformed, diploid |
|
75 | general cells |
JCRB9087 |
RPMI 1846 |
hamster, Syrian |
melanotic melanoma |
melanotic melanoma |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.